image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 7 days, don't miss out!

Essentra

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ESNT
  • Price:
  • 231.5p
Essentra has announced plans to return the proceeds from the Packaging and Filters disposals, with £90m via special dividend (c. 30p a share, on the register as at 21 March) and £60m share buy back, in aggregate 8.5% of its market value. It leaves Essentra as a pure play on Components.  Earlier, its full year update revealed results will be in line despite a soft Q4. Europe (over 50% sales) is outperforming but USA (30% sales) experienced revenue declines reflecting destocking by distributors. The smaller AsiaPac experienced disruption from Covid lockdowns, albeit China’s pivot should improve demand.  Under the current CEO, Components has already tripled turnover in the past decade and on 1 December announced the “eps accre ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe